Propranolol: a new pharmacologic approach to counter retinopathy of prematurity progression
Despite the evident progress in neonatal medicine, retinopathy of prematurity (ROP) remains a serious threat to the vision of premature infants, due to a still partial understanding of the mechanisms underlying the development of this disease and the lack of drugs capable of arresting its progressio...
Main Authors: | Francesca Pascarella, Rosa Teresa Scaramuzzo, Alessandro Pini, Maurizio Cammalleri, Paola Bagnoli, Massimiliano Ciantelli, Luca Filippi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-01-01
|
Series: | Frontiers in Pediatrics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fped.2024.1322783/full |
Similar Items
-
Propranolol 0.2% Eye Micro-Drops for Retinopathy of Prematurity: A Prospective Phase IIB Study
by: Luca Filippi, et al.
Published: (2019-05-01) -
Refractive Outcome in Preterm Newborns With ROP After Propranolol Treatment. A Retrospective Observational Cohort Study
by: Luca Filippi, et al.
Published: (2019-11-01) -
A promising case of preclinical-clinical translation: β-adrenoceptor blockade from the oxygen-induced retinopathy model to retinopathy of prematurity
by: Maurizio Cammalleri, et al.
Published: (2024-06-01) -
Decoupling Oxygen Tension From Retinal Vascularization as a New Perspective for Management of Retinopathy of Prematurity. New Opportunities From β-adrenoceptors
by: Luca Filippi, et al.
Published: (2022-01-01) -
Fetal oxygenation in the last weeks of pregnancy evaluated through the umbilical cord blood gas analysis
by: Luca Filippi, et al.
Published: (2023-04-01)